Restored balance. Lasting health.
Our mission
At Atisama we’re pioneering splice-switching oligonucleotides that return gene transcription pathways to their optimal form, shifting the molecular balance from disease toward resolution.
Our science
Rebalance inflammation
We target the receptor for advanced glycation end-products to shift biology from chronic inflammation toward resolution.
Splice-switching therapeutics
Our splice-switching oligonucleotides convert pro-inflammatory receptor variants into their protective, anti-inflammatory forms.
Precision treatments
By harnessing advanced RNA-targeting science, we are developing new life-changing treatments for patients who need it most.
Our team
Director 04
Board Director
Director 05
Board Director
Board of directors
Director 01
Board Director
Director 02
Board Director
Director 03
Board Observer
Team name 07
Job description
Team name 08
Job description
Team name 09
Job description
Team
Team name 01
Job description
Team name 02
Job description
Team name 03
Job description
Team name 04
Job description
Team name 05
Job description
Team name 06
Job description
Team name 10
Job description
Team name 11
Job description
Team name 12
Job description
Founders
Merlin Thomas
Founder
Steve Wilton
Scientific Co-Founder
Kevin Pfleger
Scientific Co-Founder
Our investors & partners
Work with us
We are looking for fiercely innovative and entrepreneurial colleagues that feel as passionate as we do about applying cutting-edge research to fighting disease. If this is you, apply at talent@atisama.com